{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-25-000097","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.114817+00:00","generated_at":"2026-05-18T05:31:34.565695+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"Lifecore Biomedical approves FY2026 bonus plan for executives with EBITDA, revenue targets","bullets":["Board approved FY2026 cash bonus plan for CEO Paul Josephs (100% target), CFO Ryan Lake (60%), and CAO Thomas Salus (50%).","Bonus weighted 80% to Adjusted EBITDA and development revenue; max payout 200% of target; no bonus if minimum EBITDA unmet.","Individual performance goals and company business goals each weighted 10%.","Salus receives 125% of any bonus earned per employment agreement; all bonuses subject to clawback policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-25-000097","json":"https://secwatch.observer/filing/0001005286-25-000097.json","markdown":"https://secwatch.observer/filing/0001005286-25-000097.md","text":"https://secwatch.observer/filing/0001005286-25-000097.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/0001005286-25-000097-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/lndc-20250715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:31:34.565695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}